undamentalytics Newsletter
Sign in

Artivion, Inc. income statement

In fiscal 2025, Artivion, Inc. reported revenue of $441m, up 13.6% on the year before, operating income of $33.7m (a 7.6% margin) and net income of $9.8m, or $0.21 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue112117120132141145146180190263276253299314354389441471
Cost of revenue424844475053556161909385101111125140157168
Gross profit70687685909191119129173183168198203229249284304
Research and development567789101319232324363929283135
Selling, general and administrative5049576568747592101141143141170157209181226255
Operating income1410121314952289172866393421
Interest expense000000035161517171825342724
Income before tax14711122396184−62−17−15−15−22−8152
Income tax63447128−0−4−0−0049655
Net income94781674114−32−17−15−19−31−1310−3
Diluted EPS$0.30$0.14$0.26$0.28$0.57$0.25$0.14$0.32$0.11−$0.08$0.05−$0.44−$0.38−$0.48−$0.75−$0.32$0.21−$0.06
Diluted shares (average)28m28m28m27m28m28m29m33m34m36m38m38m39m40m41m42m47m50m
EBITDA191417182015113018273523322929635645

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AORT vs ARAYAORT vs ATRCAORT vs BVS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Artivion, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Artivion, Inc.